Federally, the 2C compounds named in 21 CFR 1308.11 are classified in Schedule I. At Mind Medicine Law, we compiled these 14 entries from the eCFR text of 21 CFR 1308.11 (as of 2026-11-06, checked 2026-11-15). Each row of the table below shows the paragraph number and Drug Enforcement Administration (DEA) code.
Which 2C Drugs Are Illegal Under Federal Law?
Under federal law, 14 specific substances associated with the 2C nomenclature are explicitly classified as Schedule I controlled substances. Title 21 of the Code of Federal Regulations, 21 CFR 1308.11, establishes that Schedule I consists of the drugs and other substances listed by whatever official name, common name, chemical name, or brand name designated. Paragraph (a) assigns each listed drug or substance an individual Drug Enforcement Administration (DEA) Controlled Substances Code Number.
Section 1308.11(d) specifies that unless excepted or listed in another schedule, the listing applies to any material, compound, mixture, or preparation containing any quantity of the named hallucinogenic substances. This coverage extends to their salts, isomers, and salts of isomers whenever the existence of such forms is possible within the specific chemical designation. In this subsection, 14 distinct entries correspond to 2C designations: 11 2C entries and 3 NBOMe entries carrying parenthetical 2C names. The paragraph adds that, "for purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers."
The statutory framework governing these listed substances is established in Title 21 of the United States Code. Under 21 USC 812(b)(1), Schedule I substances satisfy three statutory findings. The drug has a high potential for abuse and no currently accepted medical use in treatment in the United States. There is also a lack of accepted safety for its use under medical supervision.
Federal restrictions on possession and distribution are governed by distinct statutory sections. Under 21 USC 841(a), except as authorized by statute, it shall be unlawful for any person knowingly or intentionally to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance. For individual possession, 21 USC 844(a) provides: "It shall be unlawful for any person knowingly or intentionally to possess a controlled substance unless such substance was obtained directly, or pursuant to a valid prescription or order, from a practitioner, while acting in the course of his professional practice, or except as otherwise authorized by this subchapter or subchapter II." A compound that is neither named nor covered as a salt or isomer of a named entry can be reached through the analogue provisions described below, but only if the statutory conditions are met.
Schedule I Hallucinogenic 2C Substances in Federal Regulations
| Compound | 21 CFR 1308.11(d) entry | DEA code | On-site guide |
|---|---|---|---|
| 2C-B | (d)(3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 | 2C-B guide |
| 2C-T-7 | (d)(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine | 7348 | |
| 2C-E | (d)(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine | 7509 | |
| 2C-D | (d)(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine | 7508 | |
| 2C-C | (d)(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine | 7519 | |
| 2C-I | (d)(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine | 7518 | |
| 2C-T-2 | (d)(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine | 7385 | |
| 2C-T-4 | (d)(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine | 7532 | |
| 2C-H | (d)(44) 2-(2,5-Dimethoxyphenyl)ethanamine | 7517 | |
| 2C-N | (d)(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine | 7521 | |
| 2C-P | (d)(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine | 7524 | |
| 25I-NBOMe (2C-I-NBOMe) | (d)(55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 7538 | |
| 25C-NBOMe (2C-C-NBOMe) | (d)(56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 7537 | |
| 25B-NBOMe (2C-B-NBOMe) | (d)(57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 7536 |
What Does 2C Mean in the Schedule?
The regulatory text of 21 CFR 1308.11 does not explain what the letters "2C" stand for. In the eCFR text, the listed designations are chemical names. Shorter terms such as "2C-B", "2C-T-7", or "2C-E" appear only in parentheses or in the listed "other names" text beside the chemical entries.
A review of the chemical names listed in 21 CFR 1308.11(d) shows specific shared structural phrasing across the phenethylamine group. Each listed phenethylamine name contains "2,5-dimethoxy" and "phenyl" followed by ethanamine or phenethylamine. What distinguishes each compound in the schedule is the specific group positioned at the 4 position.
The listed variations at the 4 position include bromo (2C-B), propylthio (2C-T-7), ethyl (2C-E), methyl (2C-D), chloro (2C-C), iodo (2C-I), ethylthio (2C-T-2), isopropylthio (2C-T-4), nitro (2C-N), and propyl (2C-P). In the case of 2C-H, there is no substitution group at the 4 position. The three listed NBOMe entries add an N-(2-methoxybenzyl) group to the corresponding phenethylamine structure: 2C-I-NBOMe, 2C-C-NBOMe, and 2C-B-NBOMe.
Federal regulation places all 14 of these compounds under the regulatory category of hallucinogenic substances in paragraph (d). Beyond these chemical descriptions and listed alternate names, the regulation text read on November 15, 2026 provides no historical background, mentions no individual discoverer, and provides no pharmacological mechanism.
What About 2C Compounds Not on the List?
A compound that is not named in 21 CFR 1308.11, and is not a salt or isomer of a named entry, is not scheduled by name.
Under 21 USC 802(32)(A), a substance must meet specific conjunctive statutory requirements to qualify as a controlled substance analogue. Clause (i) requires that the chemical structure of the substance is substantially similar to the chemical structure of a controlled substance in Schedule I or II. In addition to this structural requirement, the substance must satisfy either clause (ii) or clause (iii).
Clause (ii) requires that the compound has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than that of a controlled substance in Schedule I or II. Alternatively, clause (iii) requires that, with respect to a particular person, such person represents or intends the substance to have such an effect. Read together, clause (i) is required and either clause (ii) or clause (iii) must also be met.
Statutory exemptions limit the scope of this definition. Under 21 USC 802(32)(C), the term does not include a controlled substance. It also excludes any substance with an approved new drug application. Two further exclusions apply. One covers a substance under an investigational new drug exemption under section 355 of Title 21, to the extent conduct is pursuant to it. The other covers any substance, to the extent not intended for human consumption before such an exemption takes effect.
21 USC 813(a) states the consequence. A controlled substance analogue shall, to the extent intended for human consumption, be treated, for the purposes of any Federal law, as a controlled substance in Schedule I. Whether an unlisted substance meets these statutory elements is not predetermined by regulation and must be determined on a case-by-case basis. Our 4-AcO-DMT guide explains the Federal Analogue Act with a worked example of a substance not listed by name, and our legal highs guide covers legal highs generally.
Who This Is Not For and What Would Change the Answer
If you need individual legal advice, defense counsel or a state-specific reading, talk to a licensed attorney in your state. Nothing here covers dosing, effects, sourcing or synthesis.
State controlled-substance laws can differ from the federal rules above and are not summarized here. Our state-by-state tool covers psilocybin, DMT, MDMA, ketamine and ibogaine, not 2C compounds.
Three official actions would change the federal answers above:
- A DEA final rule that adds, removes or rewords 2C entries in 21 CFR 1308.11.
- An Act of Congress amending 21 USC 844, 802(32) or 813.
- A court ruling on the analogue provisions.
Verdict on 2C Drugs Legal Status
For a reader asking whether 2C drugs are legal under federal law, the 14 compounds named in 21 CFR 1308.11(d) (as of 2026-11-06, checked 2026-11-15) are classified as Schedule I controlled substances. A compound that is neither named nor a salt or isomer of a named entry can be treated as Schedule I only if it meets the analogue conditions of 21 USC 802(32) and is intended for human consumption under 21 USC 813(a).
This conclusion is based entirely on our compilation and reading of the federal regulatory text in 21 CFR 1308.11 and the federal statutory provisions in Title 21 of the United States Code.
The legal framework would change if the DEA issues a rule modifying 21 CFR 1308.11, if Congress amends Title 21 of the United States Code, or if federal court decisions alter the interpretation of analogue provisions. Read the 21 CFR 1308.11 entry on eCFR for the current text, and ask a licensed attorney in your state how state law treats these compounds.